Literature DB >> 21166567

Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.

Courtney A Jensen1, Michael D Chan, Thomas P McCoy, J Daniel Bourland, Allan F deGuzman, Thomas L Ellis, Kenneth E Ekstrand, Kevin P McMullen, Michael T Munley, Edward G Shaw, James J Urbanic, Stephen B Tatter.   

Abstract

OBJECT: As a strategy to delay or avoid whole-brain radiotherapy (WBRT) after resection of a brain metastasis, the authors used high-resolution MR imaging and cavity-directed radiosurgery for the detection and treatment of further metastases.
METHODS: Between April 2001 and October 2009, 112 resection cavities in 106 patients with no prior WBRT were treated using radiosurgery directed to the tumor cavity and for any synchronous brain metastases detected on high-resolution MR imaging at the time of radiosurgical planning. A median dose of 17 Gy to the 50% isodose line was prescribed to the gross tumor volume, defined as the rim of enhancement around the resection cavity. Patients were followed up via serial imaging, and new brain metastases were generally treated using additional radiosurgery, with salvage WBRT typically reserved for local treatment failure at a resection cavity, numerous failures, or failures occurring at short time intervals. Local and distant treatment failures were determined based on imaging results. Kaplan-Meier curves were generated to estimate local and distant treatment failure rates, overall survival, neurological cause-specific survival, and time delay to salvage WBRT.
RESULTS: Radiosurgery was delivered to the resection cavity alone in 57.5% of patients, whereas 24.5% of patients also received treatment for 1 synchronous metastasis, 11.3% also received treatment for 2 synchronous metastases, and 6.6% also received treatment for 3-10 additional lesions. The median overall survival was 10.9 months. Overall survival at 1 year was 46.8%. The local tumor control rate at 1 year was 80.3%. The disease control rate in distant regions of the brain at 1 year was 35.4%, with a median time of 6.9 months to distant failure. Thirty-nine of 106 patients eventually received salvage WBRT, and the median time to salvage WBRT was 12.6 months. Kaplan-Meier estimates showed that the rate of requisite WBRT at 1 year was 45.9%. Neurological cause-specific survival at 1 year was 50.1%. Leptomeningeal failure occurred in 8 patients. One patient had treatment failure within the resection tract. Seven patients required reoperation: 2 for resection cavity recurrence, 3 for radiation necrosis, 1 for hydrocephalus, and 1 for a CSF cutaneous fistula. On multivariate analysis, a preoperative tumor diameter > 3 cm was predictive of local treatment failure.
CONCLUSIONS: Cavity-directed radiosurgery combined with high-resolution MR imaging detection and radiosurgical treatment of synchronous brain metastases is an effective strategy for delaying and even foregoing WBRT in most patients. This technique provides acceptable local disease control, although distant treatment failure remains significant.

Entities:  

Mesh:

Year:  2010        PMID: 21166567      PMCID: PMC3789371          DOI: 10.3171/2010.11.JNS10939

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine.

Authors:  D Balériaux; C Colosimo; J Ruscalleda; M Korves; G Schneider; K Bohndorf; G Bongartz; M A van Buchem; M Reiser; K Sartor; M W Bourne; P M Parizel; G R Cherryman; I Salerio; A La Noce; G Pirovano; M A Kirchin; A Spinazzi
Journal:  Neuroradiology       Date:  2002-03       Impact factor: 2.804

2.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  Optimizing intracranial metastasis detection for stereotactic radiosurgery.

Authors:  Johnathan A Engh; John C Flickinger; Ajay Niranjan; Devin V Amin; Douglas S Kondziolka; L Dade Lunsford
Journal:  Stereotact Funct Neurosurg       Date:  2007-01-26       Impact factor: 1.875

4.  Importance of MR technique for stereotactic radiosurgery.

Authors:  Bernadine R Donahue; Judith D Goldberg; John G Golfinos; Edmond A Knopp; Jessica Comiskey; Stephen C Rush; Kerry Han; Vandana Mukhi; Jay S Cooper
Journal:  Neuro Oncol       Date:  2003-10       Impact factor: 12.300

5.  Stereotactic radiosurgery of the postoperative resection cavity for brain metastases.

Authors:  Scott G Soltys; John R Adler; John D Lipani; Paul S Jackson; Clara Y H Choi; Putipun Puataweepong; Scarlett White; Iris C Gibbs; Steven D Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-19       Impact factor: 7.038

6.  Tumor bed radiosurgery after resection of cerebral metastases.

Authors:  David Mathieu; Douglas Kondziolka; John C Flickinger; David Fortin; Brendan Kenny; Karine Michaud; Sanjay Mongia; Ajay Niranjan; L Dade Lunsford
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654

7.  Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy.

Authors:  Paul K Kim; Thomas L Ellis; Volker W Stieber; Kevin P McMullen; Edward G Shaw; Thomas P McCoy; Ralph B D'Agostino; J Daniel Bourland; Allan F DeGuzman; Kenneth E Ekstrand; Michael R Raber; Stephen B Tatter
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

8.  Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.

Authors:  Ly Do; Richard Pezner; Eric Radany; An Liu; Cecil Staud; Benham Badie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-14       Impact factor: 7.038

9.  Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases.

Authors:  Jay Jagannathan; Chun-Po Yen; Dibyendu Kumar Ray; David Schlesinger; Rod J Oskouian; Nader Pouratian; Mark E Shaffrey; James Larner; Jason P Sheehan
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

View more
  63 in total

1.  Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis?

Authors:  Riccardo Soffietti; Roberta Rudà; Nicholas Trakul; Eric L Chang
Journal:  Neuro Oncol       Date:  2016-01       Impact factor: 12.300

Review 2.  The impact of cerebral metastases growth pattern on neurosurgical treatment.

Authors:  Marcel A Kamp; Philipp J Slotty; Jan F Cornelius; Hans-Jakob Steiger; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2016-07-09       Impact factor: 3.042

3.  Postoperative local fractionated radiotherapy for resected single brain metastases.

Authors:  Ahmad Walid Ayas; Stefan Grau; Karolina Jablonska; Daniel Ruess; Maximilian Ruge; Simone Marnitz; Roland Goldbrunner; Martin Kocher
Journal:  Strahlenther Onkol       Date:  2018-09-14       Impact factor: 3.621

4.  Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.

Authors:  Anthony L Asher; Mohammed Ali Alvi; Mohamad Bydon; Nader Pouratian; Ronald E Warnick; James McInerney; Inga S Grills; Jason Sheehan
Journal:  J Neurooncol       Date:  2021-01-22       Impact factor: 4.130

5.  Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.

Authors:  Ammoren E Dohm; Ryan Hughes; William Wheless; Michael Lecompte; Claire Lanier; Jimmy Ruiz; Kounosuke Watabe; Fei Xing; Jing Su; Christina Cramer; Adrian Laxton; Stephen Tatter; Michael D Chan
Journal:  J Neurooncol       Date:  2018-10-26       Impact factor: 4.130

6.  The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery.

Authors:  D Clay Cochran; Michael D Chan; Mebea Aklilu; James F Lovato; Natalie K Alphonse; J Daniel Bourland; James J Urbanic; Kevin P McMullen; Edward G Shaw; Stephen B Tatter; Thomas L Ellis
Journal:  J Neurosurg       Date:  2012-03-02       Impact factor: 5.115

7.  A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy.

Authors:  Diandra N Ayala-Peacock; Ann M Peiffer; John T Lucas; Scott Isom; J Griff Kuremsky; James J Urbanic; J Daniel Bourland; Adrian W Laxton; Stephen B Tatter; Edward G Shaw; Michael D Chan
Journal:  Neuro Oncol       Date:  2014-02-20       Impact factor: 12.300

Review 8.  Tumor bed radiosurgery: an emerging treatment for brain metastases.

Authors:  Mark J Amsbaugh; Warren Boling; Shiao Woo
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

9.  Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy.

Authors:  Emory R McTyre; Adam G Johnson; Jimmy Ruiz; Scott Isom; John T Lucas; William H Hinson; Kounosuke Watabe; Adrian W Laxton; Stephen B Tatter; Michael D Chan
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 10.  Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship.

Authors:  Colette J Shen; Michael Lim; Lawrence R Kleinberg
Journal:  Curr Treat Options Oncol       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.